Reporter 452, 22 May 2000


Cancer study funded

A University research team working on the use of viruses to harness cancer treatments has won three yearsí funding from the Association for International Cancer Research.

Dr Adrian Whitehouse and colleagues in the molecular medicine unit at St Jamesís University Hospital were awarded £58,000 for work on gene therapy for colorectal cancer - a disease that accounts for 20,000 deaths annually in the UK and is the most common cause of non-smoking-related cancer mortality.

The Leeds team hopes to use virus-based vectors to replace mutated genes with normal ones. By infecting the cancer cells, the vector may halt the growth of the tumour by delivering the correct genes.

Further information is available on the departmental website:
http://www.leeds.ac.uk/medicine/res_school/mol_med/groups/ace.htm

[Main news stories | News in brief | Events | Notice board]


HTML by Karen Cooper